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Abstract 
Background: Zfp819, a member of the Krüppel-associated box (KRAB) family, encodes a spermatogenic cell-specific 
transcription factor. Zfp819-overexpression induces apoptosis and inhibits proliferation in somatic cell lines.
Results: In the present study, we examined the cellular effects of Zfp819 in a male germ cell line (GC-2 cells). Over-
expression of Zfp819 demonstrated an increase in the number of apoptotic cells, leading to inhibition of proliferation 
in GC-2 cells. We further investigated genes regulated by ZFP819 using microarray analysis and chromatin-immuno-
precipitation combined with microarray analysis (ChIP-chip) in GC-2 cells. We identified 118 downregulated genes 
in Zfp819-overexpressing GC-2 cells using microarray analysis. ChIP-chip assay revealed that 1011 promoter sites 
(corresponding to 262 genes) were specifically enriched in GC-2 cells transfected with Zfp819. Two genes (trinucleo-
tide repeat containing 6b and annexin A11) were commonly found when we compared the data between microarray 
and ChIP-chip analyses. Consistent with these results, Zfp819 overexpression significantly reduced the transcript levels 
of the two genes by binding to their promoter regions. Tissue distribution analysis indicated that both genes were 
predominantly expressed in testis. It has been reported that these two genes function in apoptosis.
Conclusion: Collectively, our study provides inclusive information on germ cell-specific gene regulation by ZFP819, 
which is involved in apoptosis, to maintain the integrity of spermatogenesis.
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Background
Spermatogenesis is a unique and highly elaborated pro-
cess that requires a highly organized and tightly regulated 
network of genes, many of which are spermatogenic-cell-
specific. Previous reports investigated gene expression 
profiles in mouse spermatocytes and round spermatids 
and found that the proportions of testis-specific genes 
in spermatocytes and round spermatids were 11% 
(230 genes) and 22% (467 genes), respectively [1, 2]. 
Despite the presence of many unique genes expressed in 
spermatogenic cells, the characteristics of their associ-
ated transcriptional network(s) are largely unknown.
The Krüppel-associated box and C2H2-type zinc 
finger motifs (KRAB-ZF) family, one of the largest 
transcription factor groups in vertebrates has a tran-
scriptional repressive activity by binding to DNA in a 
sequence-specific manner [3]. The members of KRAB-
ZF family are generally expressed in various tissues and 
are involved in diverse processes including apoptosis, 
cell proliferation, and tumorigenesis [3]. It has been 
reported that a number of the KRAB-ZF genes on a cer-
tain chromosome are abundantly expressed in testis and 
fetal brain and may have important functions in these 
tissues [4]. Previously, we comprehensively identified 
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and characterized the KRAB-ZF genes in the reproduc-
tive tissues (testis or ovary) [5]. Three KRAB-ZF genes 
were specifically or predominantly expressed in the 
gonads. Of them, Zfp819, which was specific to sper-
matogenic cells, was analyzed in detail. We found that 
the overexpression of Zfp819 affected cell proliferation 
and induced apoptosis in somatic cell lines. The over-
expression of Zfp819 changed the expression of B cell 
lymphoma protein-2 (BCL-2) and poly(ADP-ribose) 
polymerase (PARP) [5].
To date, the target genes of only a few KRAB-ZF 
members have been discovered [6–9]. In the present 
study, we investigated the transcriptional network of 
Zfp819 through genome-wide approaches in a germ 
cell line. We found that the overexpression of Zfp819 
affected cell proliferation and induced apoptosis in 
GC-2 cells. Microarray analysis revealed 1737 differ-
entially expressed genes in Zfp819-overexpressing cells 
compared with mock-transfected cells, and of them, 
118 genes were down-regulated by ZFP819. In addition, 
chromatin immunoprecipitation (ChIP)-chip analy-
sis revealed 1011 promoter sites enriched by ZFP819. 
Interestingly, two genes encoding trinucleotide repeat 
containing 6b (TNRC6B) and annexin A11 (ANXA11) 
were found to overlap between the microarray and 
ChIP results. These genes were verified by ChIP-PCR 
and promoter assays. They also demonstrated a pre-
dominant expression in testis and were previously 
reported to have important functions in apoptosis. 
Collectively, our results revealed for the first time to 
the best of our knowledge using GC-2 cells a germ cell-




Mouse adult tissues and GC-2 cells transfected with 
pcDNA3.1/myc or pcDNA3.1/myc-Zfp819 were 
assessed. All animal investigations were conducted 
according to the guidelines of the Animal Care and Use of 
the Gwangju Institute of Science and Technology. Total 
RNA samples were extracted using TRIzol™ Reagent 
(MRC) according to manufacturer’s protocol, and reverse 
transcribed with Omniscript reverse transcriptase (Qia-
gen). Complementary DNA samples prepared from 
mouse adult tissues were amplified with primers specific 
for each of the reproductive KRAB-ZF genes (Additional 
file 1: Table S1). Quantitative real-time PCR (qRT-PCR) 
was performed using SYBR Green Taq polymerase mix 
(TaKaRa Bio, Inc.). All of the reactions contained 10  µl 
of SYBR Green Master Mix and 50–100  ng of template 
cDNA. Glyceraldehyde 3-phosphate dehydrogenase 
(Gapdh) was used as an internal control.
Dual‑luciferase reporter assay
GC-2 cells (4.0 × 105 cells/well) were seeded onto 24-well 
plates and incubated at 37  °C for 24  h. For repressive 
activity of Zfp819-KRAB, when the cells reached approx-
imately 80–90% confluence, they were co-transfected 
with 250  ng of pcDNA3.1/myc-Zfp819-KRAB, 250  ng 
of a firefly luciferase-encoding vector (pGL3-promoter, 
Invitrogen), and 5  ng of pRL-TK (Renilla used as an 
internal control for normalization of transfection effi-
ciency in the absence and presence of Zfp819 overexpres-
sion). After 24  h, the cells were lysed with passive lysis 
buffer (Promega), dual luciferase assays were performed 
with a Luciferase Reporter Assay kit (Promega), and the 
luciferase activity was measured using a Centro LB 960 
DLReady microplate illuminometer (Berthold Technolo-
gies). GAL4-DBD was used as a basic control, and KOX1-
DBD was used as a positive control. For promoter activity 
of Zfp819, Tnrc6b or Anxa11 promoter regions were 
inserted into pGL-promoter (Invitrogen). When the cells 
reached approximately 80–90% confluence, they were 
co-transfected with 250 ng of pcDNA3.1/myc-Zfp819 or 
pcDNA3.1/myc, 250  ng of a firefly luciferase-encoding 
vector (pGL3-promoter, Invitrogen), and 5 ng of pRL-TK 
(Renilla). Each experiment was repeated three independ-
ent times in triplicate.
Cell proliferation assay using MTT
Cell proliferation was measured using the 3-(4,5-dimeth-
ylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 
assay. In brief, GC-2 cells were grown in 6-well plates for 
1  day at a density of 3.0 ×  105cells/well. After an addi-
tional 24  h, cells were transfected with pcDNA3.1/myc 
or pcDNA3.1/myc-Zfp819 plasmids using Lipofectamine 
2000 (Invitrogen; 10  µl reagent per 5  µg DNA). After 
48 h, the cells were exposed to 1 ml/well MTT solution 
(1.5 mg/ml) at 37  °C for 1.5 h in medium. The medium 
was removed, 0.04  N isopropanol in HCl was added to 
solubilize the formazan crystals, and the plates were gen-
tly agitated at room temperature for 10 min in the dark-
ness. Cell proliferation was measured at 570 and 650 nm 
using an ELISA reader. Each experiment was performed 
three independent times in triplicate.
Flow cytometry and TUNEL assay
Cells were transfected with pcDNA3.1/myc (empty vec-
tor) or pcDNA3.1/myc-Zfp819 plasmids and incubated 
at 37  °C for 24 h. For the analysis of cell cycle distribu-
tion, GC-2 cells were seeded (3.0  ×  105 cells/well) in 
6-well plates for 24  h, harvested with trypsin–EDTA 
(TE, Gibco), and fixed with 70% ethanol for 1.5 h on ice 
in the dark. The cells were then collected by centrifuga-
tion, washed once with ice-cold PBS, and incubated with 
500  µl of propidium iodide (PI) solution (50  µg/ml) for 
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30 min at 37 °C in the dark. Finally, the cells were resus-
pended in PBS then analyzed by flow cytometry. For the 
detection of apoptotic cells, the TUNEL assay was per-
formed with an Apop Tag® Plus Peroxidase In Situ Apop-
tosis Detection kit (Chemicon). Cells (3.0  ×  105 cells/
well) were plated in 6-well plates, transfected as indicated 
for 48  h, and then fixed with 4% formaldehyde at room 
temperature for 10  min. The cells were then washed 
with PBS, mixed with 55  µl/well of TdT enzyme, and 
incubated at 37 °C in a humidified chamber for 1 h. The 
reaction was stopped with stop/wash buffer, DNA was 
counterstained with Hoechst 33,342 (Sigma), and the 
cells were visualized by confocal microscopy. Each exper-
iment was performed three times in triplicate.
Immunoblotting
The transfected cell lysates were prepared with 1% 
sodium dodecyl sulfate (SDS). Equal amounts of protein 
(30  µg) were separated by 8% SDS–polyacrylamide gel 
electrophoresis and transferred onto a polyvinylidene 
difluoride (PVDF) membranes (Millipore corporation). 
Membranes were hybridized for 17  h at 4  °C or 1  h at 
room temperature with primary antibodies including: 
anti-Myc (1:1000, Cell signaling), anti-TNRC6B (1:1000, 
Millipore), anti-ɑ-tubulin (1:1000, Millipore), and anti-
GAPDH (1:1000, Bio-RAD) antibodies. Bound IgG 
was detected following 1  h incubation with horseradish 
peroxidase-conjugated secondary antibodies (Jackson 
ImmunoResearch Laboratories) and the Luminol and 
Stable peroxidase solutions (ThermoFisher scientific).
Microarray analysis
GC-2 cells were transfected with pcDNA3.1/myc (empty 
vector) or pcDNA3.1/myc-Zfp819 using Lipofectamine 
2000 reagent (Invitrogen). Total RNA was extracted 
using RNeasy columns (Qiagen) according to the manu-
facturer’s instructions. For control and test RNAs, the 
synthesis of target cRNA probes and hybridization were 
performed using Agilent’s LowInput QuickAmp Labeling 
Kit (Agilent Technology, USA) as per the manufacturer’s 
instructions. The hybridized microarrays were washed as 
per the manufacturer’s washing protocol (Agilent Tech-
nology). This analysis was repeated three times.
ChIP‑chip assay
ChIP assay was performed using the Chromatin Immu-
noprecipitation Assay Kit (Millipore Upstate) as pre-
viously described [10]. In brief, GC-2 cells transfected 
with pcDNA3.1/myc (mock without protein expression) 
or pcDNA3.1/myc-Zfp819 plasmids were cross-linked 
by adding 1% formaldehyde (37%) for 10  min in the 
humidified chamber (at 37  °C with 5% CO2), followed 
by a quenching step with 125  mM glycine. Cells were 
rinsed twice with 1× PBS and resuspended in 1% SDS 
lysis buffer containing protease inhibitor cocktail (PIC). 
Sonicated chromatin was immunoprecipitated with 
α-myc antibody (Cell Signaling). Antibody-bound chro-
matin complexes were then captured with protein A 
agarose beads blocked with salmon sperm DNA, and 
eluted in SDS buffer. Formaldehyde crosslinking was 
reversed, followed by DNA purification by phenol–
chloroform extraction. The immunoprecipitated and 
input DNA were amplified using a whole genome ampli-
fication kit (GenomePlex® Complete Whole Genome 
Amplification Kit) as recommended by the manufac-
turer. Each 2.5–5  µg of cyanine 3-labeled and cyanine 
5-labeled DNA target were mixed and then resuspended 
with 2× hybridization buffer, Cot-1 DNA, and Agilent 
10× blocking agent. Before hybridization to the array, 
the 260  µl hybridization mixtures were denatured at 
95  °C or 3 min and incubated at 37  °C for 30 min. The 
hybridization mixtures were centrifuged at 17,900×g 
for 1  min and directly pipetted onto the Mouse Pro-
moter 2 × 400 K microarray. This array covers 415,814 
probes (~19,000 genes as represented by RefSeq, probes 
are spaced 93 bp apart). The arrays hybridized at 65 °C 
for 40  h in an Agilent Hybridization oven (Agilent 
Technology). The hybridized microarrays were washed 
as per the manufacturer’s washing protocol (Agilent 
Technology).
Gene silencing using siRNAs
siRNA-mediated gene silencing of Tnrc6b and Anxa11 
was performed using siRNA duplexes (Bioneer). The 
target sequences of siRNAs were ACU UCU GGA GAC 
UAU CGA A(dTdT) (Anxa11) and CUG GUU ACC 
UGC CAA AUC U(dTdT) (Tnrc6b). In brief, GC-2 
cells were grown in 6-well plates for 1  day at a density 
of 6.0  ×  105  cells/well. After an additional 24  h, cells 
were transfected with of control siRNA, Tnrc6b siRNA, 
or Anxa11 siRNA (25  nM) using Lipofectamine 2000 
(Invitrogen; 6.25  µl reagent). After 48  h, total RNA was 
extracted using TRIzol™ Reagent (MRC) according to 
manufacturer’s protocol, and reverse transcribed with 
Omniscript reverse transcriptase (Qiagen). The knock-
down efficiency was confirmed by RT-PCR with primers 
specific for Tnrc6b and Anxa11.
Statistical analysis
Each experiment was performed three times. Each time, 
measurements were conducted on three samples with 
the same design and averaged. Data are represented as 
mean ± standard error of mean (mean ± SEM.). Statisti-
cal analysis was calculated by Student’s t test.
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Results
Repressive activity of Zfp819 in germ cell line (GC‑2 cell)
We previously reported that the KRAB domain of 
Zfp819 has repressive activity using the GAL4-UAS sys-
tem in somatic cell lines (HEK 293T and NIH3T3) [5]. 
To confirm the repressive activity of Zfp819 in the germ 
cell line as well, we performed a reporter assay using 
GAL4-DBD-Myc constructs fused to the KRAB domain 
sequences from Zfp819 and a luciferase expression con-
struct containing an enhancer that specifically bound to 
GAL4 (GAL4-UAS) (Fig. 1a). These two constructs were 
cotransfected into GC-2 cells, which are derived from 
mouse spermatocytes [11]. The controls included KOX1, 
which is a KRAB-ZF known to strongly repress tran-
scription, and GAL4-DBD-Myc alone. Western blotting 
of cells transfected with a construct encoding Zfp819-
GAL4-DBD-Myc confirmed that the recombinant pro-
tein was successfully expressed in GC-2 cells (Fig.  1b). 
Then, monitoring of luciferase activity demonstrated that 
each of the tested KRAB domains (KOX1 and Zfp819) 
reduced luciferase activity compared with GAL4-DBD-
Myc alone, indicating that these domains can repress 
transcription in GC-2 cells (Fig. 1c). Taken together, these 
results indicate that we successfully identified Zfp819 
with transcription-repressing activity in GC-2 cells.
Inhibition of proliferation and induction of apoptosis 
in Zfp819‑overexpressing cells
A previous study reported that the overexpression of 
Zfp819 can induce apoptosis in somatic cell lines (NIH 
3T3 and HEK 293T), thereby inhibiting cell proliferation 
[5]. To confirm whether the effects of Zfp819 also occur 
in germ cells, we transfected pcDNA3.1 or pcDNA3.1-
Zfp819 plasmids into GC-2 cells. After 48  h, we con-
firmed the expression of Zfp819 in GC-2 cells by western 
blotting (Fig.  2a). We used the MTT assay to examine 
the effect of Zfp819 overexpression on cell proliferation, 
and found that cell growth was significantly reduced in 
Zfp819-overexpressing GC-2 cells compared with empty-
vector controls after 48 h (30% of control) (Fig. 2b). We 
also confirmed that the cell growth was not changed in 
another control, GFP-overexpressing GC-2 cells (Addi-
tional file 2: Figure S1). To determine whether this inhi-
bition of cell proliferation was caused by blockage of the 
cell cycle, we used flow cytometry to analyze the effect of 
Zfp819 on the cell cycle profile. In Zfp819-overexpressing 
cells, a higher proportion of cells were distributed in the 
sub-G1 phase (163% of control), while lower proportions 
were distributed in the S and G2/M phases (91 and 68% 
of control, respectively), suggesting that the cells were 
undergoing death (Fig. 2c, d). The G1-phase cell popula-
tion was unchanged. These changes in cell cycle distribu-
tion were observed at 48 h post-transfection (Fig. 2c, d).
We used TUNEL assays to determine whether the 
alterations in the cell populations and cell cycle distri-
butions in Zfp819-overexpressing cells were related to 
apoptosis, and observed more TUNEL-positive (i.e., 
apoptotic) signals in Zfp819-overexpressing cells than 
in controls (Fig.  2e). Our quantitative analysis demon-
strated that Zfp819 overexpression increased the number 
of apoptotic cells by approximately threefold compared 
with controls (Fig. 2f ).
Microarray and ChIP‑chip analyses 
of Zfp819‑overexpressing GC‑2 cells
To determine whether Zfp819 can repress the transcrip-
tion of endogenous genes and to identify such genes, we 
performed gene expression profile analysis (microarray) 
of mock-transfected or Zfp819-overexpressing GC-2 
cells at 24 h post-transfection. Semi quantitative RT-PCR 
analysis demonstrated that the Zfp819 transcripts were 
not detected in cells transfected with empty vector, but 
abundantly present in Zfp819-transfected cells (Fig. 3a). 
We also confirmed the expression of Zfp819 protein in 
Zfp819-transfected cells (data not shown). Microarray 
analysis of vector- and Zfp819-transfected cells using a 
Mouse GE 8 × 44 K Microarray Kit (Agilent Technology) 
revealed that a total number of 1737 genes were differen-
tially expressed in Zfp819-overexpressing cells compared 
with controls (p value < 0.05) (Fig. 3b). However, out of 
these genes, only 118 genes were downregulated in GC-2 
cells transfected with Zfp819 when we used a cutoff of 
a 20% decrease compared with control cells (Additional 
file 1: Table S2). 11 of the 118 downregulated genes have 
been previously reported to induce apoptosis when they 
were silenced (Cpt1c, Ctsh, Cbx7, Mtdh, Sf3b1, ELKS, 
Fbxw11, Itsn1, Rlim, Dyrk1b, and Rnf121) (Table  1). 
Indeed, nine of them showed decreased expression levels 
in Zfp819-transfected cells compared to controls (Addi-
tional file 2: Figure S2).
To further investigate genomic targets regulated by 
Zfp819, we applied ChIP-chip assay using mock or 
Zfp819-overexpressing GC-2 cells. For the purpose of 
this assay, GC-2 cells were transfected with the Zfp819 
plasmid, and the ChIP assay was performed at 24 h post-
transfection. Western blotting confirmed the efficient 
immunoprecipitation of ZFP819 in Zfp819-transfected 
cells compared with mock-transfected cells (Fig. 3c). Sub-
sequently, the immunoprecipitated DNAs were hybrid-
ized on Agilent’s mouse promoter array (400  K), which 
covers over 400,000 promoter sites, and then analyzed 
through Agilent’s DNA microarray scanner. As the first 
step for selecting significant data, we collected probes 
satisfying two criteria (p  <  0.05 and E-score  >  3) using 
the Peak Shape Detection V2.1 Model (Fig.  3b). In this 
process, genes demonstrating low signals on a chip and 
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random selection were removed. As a result, 3565 probes 
were selected as probes bound by ZFP819 (Fig.  3b). Of 
these 3565 probes, we found out that the majority of 
them (53.2%, 1897 probes) were located in promoter 
regions, whereas 46.8% of the bound probes were located 
within genes (Fig. 3d). Of the 1897 probes located in pro-
moter regions, we considered those with log ratio (>1) to 
search for high potential targets of ZFP819. Finally, we 
identified a total of 1011 probes corresponding to 262 
genes as targets bound by ZFP819 in GC-2 cells (p < 0.05, 
E-score  >  3, log ratio  >  1) (Additional file  1: Table S3, 
Additional file  2: Figure S3). Binding of ZFP819 to the 
targets was confirmed in several randomly selected genes 
by ChIP-PCR (Additional file  2: Figure S4). We further 
analyzed characteristics of these probes in several ways.
First, we searched for the location of the ZFP819-
bound probes from the transcription start site (TSS) 
(Fig. 4a). A total of 397 probes (39.2%) among 1011 were 
located within 1  kb (i.e., proximal promoter region) of 
the TSS (Fig.  4a). To find out highly represented bind-
ing sequences, we analyzed the sequences of 1011 
probes using a DMINDA (DNA motif identification and 
Fig. 1 Transcriptional repression by the Zfp819 protein. a Diagram of the expression and reporter constructs used for the reporter assay. b Western 
blotting of GAL4-DBD-Myc and Zfp819-GAL4-DBD-Myc expressed in GC-2 cells. c GC-2 cells were transfected and subjected to reporter assays. Both 
KRAB-ZF genes had strong repressive activities. GAL4-DBD-Myc alone and KOX1 were used as controls. Experiments were conducted in triplicate. 
The data are expressed as the mean ± SEM; *p < 0.01 versus GAL4-DBD-Myc (Student’s t test)
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Fig. 2 Behavior and apoptosis of Zfp819-overexpressing cells. Cells transfected with mock vector or Zfp819 were analyzed after 48 h. a Western 
blotting of GC-2 cells at 48 h after transfection with Zfp819 or empty vector. b Proliferation of Zfp819-overexpressing GC-2 cell line, as assessed by 
MTT assays. Experiments were repeated three times. The data are expressed as the mean ± SEM; *p < 0.001 (Student’s t test). c, d Cell cycle distribu-
tion of Zfp819-overexpressing GC-2 cells stained with propidium iodide and assessed by flow cytometry. Histograms of cell cycle distribution (c). 
All experiments were performed three times. The data are expressed as the mean ± SEM; *p < 0.05 and **p < 0.01 versus mock (Student’s t test). e 
TUNEL-positive signals (arrowheads) were observed using confocal microscopy after 48 h. f Histogram of TUNEL analysis. More than 1000 cells were 
counted. The experiment was repeated three times. The data are expressed as the mean ± SEM; *p < 0.001 versus mock (Student’s t test)
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analyses) program (Fig.  4b). The sequence logo accord-
ing to the position weight matrix demonstrated several 
sequence motifs were enriched among 1011 probes 
(1.08e−08  <  p  <  2.89e−06) (Fig.  4b). However, they 
contain only a small number of probes (9–37 probes). 
This result indicates that ZFP819 binds to a diversity of 
sequences rather than consensus elements with a limited 
number. Gene ontology analysis with a biological pro-
cess was performed by PANTHER classification system 
and demonstrated that 262 genes were involved in a 
variety of processes, such as metabolic, developmental, 
and apoptosis (Fig.  4c). Finally, we performed a ChIP-
PCR analysis several genes were subjected to a ChIP-
PCR analysis.
Fig. 3 Microarray and ChIP-chip analyses of Zfp819-overexpressing GC-2 cells. a Overexpression of Zfp819 in GC-2 cells was confirmed by RT-PCR. 
The glyceraldehyde-3-phosphate dehydrogenase (Gapdh) gene was used as a control. b Workflow of microarray and ChIP-chip analyses of Zfp819-
overexpressing GC-2 cells. c Western blotting of immunoprecipitated Zfp819 with α-Myc antibody from GC-2 cells transfected with Zfp819 or empty 
vector. d Pie chart of chromosomal distribution of Zfp819 bound peaks
Table 1 Down-regulated genes involved in apoptosis by microarray (anti-apoptotic function)
Gene symbol Description Gene ontology Expression level Ref
Cpt1c Carnitine palmitoyltransferase 1c Lipid metabolic process 0.480 [38]
Ctsh Cathepsin H Negative regulation of apoptotic process 0.495 [18]
Cbx7 Chromobox 7 Sebaceous gland development 0.509 [20]
Mtdh Metadherin Negative regulation of apoptotic process 0.518 [19]
Sf3b1 Splicing factor 3b, subunit 1 Blastocyst formation, RNA splicing 0.590 [39]
Erc1 ELKS/RAB6-interacting/CAST family member 1 Retrograde transport, endosome to Golgi 0.594 [40]
Fbxw11 (HOS) F-box and WD-40 domain protein 11 Negative regulation of NF-kappaB import into 
nucleus
0.603 [21]
Itsn1 Intersectin 1 (SH3 domain protein 1A) Negative regulation of neuron apoptotic process 0.633 [22]
Rlim (Rnf12) Ring finger protein, LIM domain interacting Regulation of dosage compensation by inactivation 
of X chromosome
0.700 [41]
Dyrk1b Dual-specificity tyrosine-(Y)-phosphorylation regu-
lated kinase 1b
Myoblast fusion 0.705 [42]
Rnf121 Ring finger protein 121 ER-associated ubiquitin-dependent protein catabolic 
process
0.736 [43]
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Identification of genes directly regulated by ZFP819
To identify genes directly regulated by ZFP819, we com-
pared the data between microarray and ChIP-chip assay 
(Fig.  5a). In total, 262 genes gathered from ChIP-chip 
assay were compared with 118 obtained from microar-
ray analysis, and only two genes that encoded TNRC6B 
and ANXA11 were commonly found in both of the data 
(Fig.  5a; Table  2). To test whether ZFP819 binds to the 
regulatory regions of these genes, we performed a ChIP-
PCR assay. To do this, we searched for the enriched 
regions of the two genes according to Log2 ratio. Peak 
graphs of Tnrc6b and Anxa11 from a ChIP-chip assay 
indicated enriched regions in Zfp819-overexpressing 
cells compared with mock cells (Fig.  5b). Considering 
the distance from the TSS, we performed a ChIP-PCR 
assay with immunoprecipitated DNAs (Fig. 5c). As dem-
onstrated in schematic structures, a ChIP-PCR assay 
was processed with primers flanking the promoter sites 
of Tnrc6b or Anxa11 (T1, −958 to −899; T2, −1815 to 
−1756; T3, −1950 to −1891; A1, −686 to −626; A2, 
−834 to −775; A3, −1015 to −956) (Fig.  5c). Of three 
regions in the Tnrc6b promoter, only one site (T1, 
−958 to −899) was determined to be a region bound by 
ZFP819. Anxa11 also revealed that one region (A1, −686 
Fig. 4 Profiling of ChIP-chip analysis. a Location of enriched probes relative to TSS. b Enriched sequences of the bound probes. c Gene ontology 
analysis according to a biological process of Zfp819 target genes from ChIP-chip assay
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to −626) was amplified in Zfp819-overexpressing cells 
(Fig. 5c).
Furthermore, we performed a promoter assay accord-
ing to the binding sites in Tnrc6b and Anxa11 promot-
ers. To this end, we generated luciferase expression 
constructs with or without the binding sites of Tnrc6b 
and Anxa11 (Fig.  6a). They were cotransfected with 
pcDNA3.1 or pcDNA3.1-Zfp819 plasmids into GC-2 
cells. Western blotting demonstrated the stable expres-
sion of Zfp819 protein in GC-2 cells in all of the tests 
Fig. 5 Validation of ChIP-chip analyses. a Venn diagram representing comparison of the data between microarray and ChIP-chip in Zfp819-overex-
pressing GC-2 cells. b Peak graphs of Tnrc6b or Anxa11 based on log2 ratio from ChIP-chip assay. Dotted lines mean log2 ratio of Tnrc6b or Anxa11 
probes from mock-transfected cells. Black lines represent log2 ratio of Tnrc6b or Anxa11 probes from Zfp819-transfected cells. c Schematic structures 
of Tnrc6b and Anxa11 promoter regions including probes. ChIP-PCR assay was performed with primer sets according to each probe sites (T1–T3 and 
A1–A3). Input was used as a control
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(Fig.  6b). Subsequently, a promoter assay using a dual-
luciferase kit was performed at 24  h post-transfection 
and luciferase activity was measured. The luciferase 
activity was significantly reduced in −958 to −899 of the 
Tnrc6b promoter in the presence of ZFP819 (Fig. 6c). On 
the other hand, luciferase activity was not changed when 
a luciferase expression construct that did not include the 
site of Tnrc6b promoter (−850 to +10) was co-trans-
fected with Zfp819 or mock (Fig. 6c). We also found that 
ZFP819 inhibited the luciferase activity driven by −686 
to −626 of the Anxa11 promoter compared with con-
trols, but not the activity driven by a region without −510 
to +10 of the Anxa11 promoter (Fig.  6d). These results 
demonstrated that ZFP819 directly bound to −958 to 
−899 in the Tnrc6b promoter and to −686 to −626 in the 
Anxa11 promoter to regulate gene expression.
Expression of Tnrc6b and Anxa11 in Zfp819‑overexpressing 
GC2‑cells
Then, we examined whether Zfp819 indeed affects tran-
scription of Tnrc6b and Anxa11 through direct binding 
to their promoter regions. In agreement with results from 
promoter assays, quantitative RT-PCR confirmed that 
both of the transcript levels of two genes were dramati-
cally decreased in Zfp819-transfected cells compared 
with mock cells (Fig. 7a). Moreover, we assessed change 
in the expression of TNRC6B at the protein level using an 
available antibody (Fig. 7b). Western blotting confirmed a 
significant reduction of TNRC6B when Zfp819 was over-
expressed in GC-2 cells (Fig. 7b). Our quantitative analy-
sis demonstrated that Zfp819 overexpression decreased 
the expression of TNRC6B by approximately 50% of 
control levels (Fig.  7c). However, we could not test the 
expression of Anxa11 because of the unavailability of an 
antibody that works in Western blot analysis. Until now, 
the expression patterns of Tnrc6b and Anxa11 have not 
been investigated in various tissues. Thus, we examined 
the tissue distributions of Tnrc6b and Anxa11 through 
in vitro expression analysis (Fig. 7d). Interestingly, Tnrc6b 
and Anxa11 were predominantly expressed in testis and 
GC-2 cells (Fig.  7d). Moreover, Western blotting also 
confirmed the predominant expression of TNRC6B 
in testis (Fig.  7e). Finally, we investigated the effects of 
siRNA-mediated gene silencing of Tnrc6b and Anxa11 in 
GC-2 cells. The knockdown efficiency was confirmed by 
RT-PCR. This analysis showed that the cell proliferation 
was significantly inhibited in Tnrc6b- or Anxa11-knock-
down GC-2 cells (Tnrc6b, 54% of control; Anxa11, 67% 
of control), consistent with the phenotype observed in 
Zfp819-transfected cells (Additional file 2: Figure S5).
Discussion
Here, we investigated the transcriptional network influ-
enced by Zfp819 in a germ cell line. We previously identi-
fied the downstream genes of Zfp819 in NIH 3T3 cells by 
overexpression-microarray analysis [5]. Because of some 
advantages, such as low cytotoxicity, minimal optimiza-
tion, and high transfection efficiency, we used the NIH 
3T3 cell line in the previous study. However, we needed 
to assess the transcriptional mechanism of Zfp819 in 
germ cells due to the specific expression of Zfp819. GC-2 
cells, originally from mouse spermatocytes, have fea-
tures in common with morphological differentiation at 
the early spermatid stages [11]. However, these features 
were not observed in another germ cell line, GC-1 cells 
derived from spermatogonia. Thus, the GC-2 cell line 
is an essential tool to study cellular effects that occur in 
spermatocytes. The functions of several transcription 
factors have been studied in GC-2 cells [12, 13]. On the 
basis of these facts, we investigated the genomic targets 
of Zfp819 using GC-2 cells, thereby looking into the 
actual downstream genes of Zfp819 in a system as close 
to germ cells as possible. It should be noted that most 
of the differentially expressed genes were found to be 
upregulated in the microarray analysis. We do not know 
how the overexpression of Zfp819 leads to the larger 
number of upregulated genes, considering that ZFP819 is 
a transcriptional repressor. Perhaps, some of these genes 
were indirectly upregulated by the downregulated genes. 
Alternatively, the upregulated genes could be the result of 
compensatory response of cells undergoing changes by 
the overexpression of Zfp819. We focused on the down-
regulated genes to identify and investigate genes directly 
regulated by ZFP819.
A comparison between the data of microarrays 
revealed that there were hardly overlapped genes in two 
cell lines (NIH 3T3 and GC-2) [5], even though Zfp819 
overexpression showed the same phenotype (induc-
tion of apoptosis). This suggests that Zfp819 regu-
lates different upstream genes in different pathways, 
Table 2 Direct targets of ZFP819 by ChIP-chip and microarray
Gene symbol Description Gene ontology ChIP‑chip (log ratio) Microarray (expression level)
Tnrc6b Trinucleotide repeat containing 
6b
Gene silencing by RNA, Regulation of 
translation
3.455 0.32
Anxa11 Annexin A11 Response to calcium ion 2.688 0.47
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eventually involved in apoptosis. Intriguingly, however, 
the different genes of TNRC6 family showed down-reg-
ulation in Zfp819-overexpressing cells, which are Tnrc6b 
and Tnrc6a in GC-2 and NIH 3T3 cells, respectively. The 
members of TNRC6 family (also GW182, glycine-trypto-
phan repeats) are well known as the major components 
in miRNAs-mediated gene silencing [14]. For the func-
tions, they interact with Argonautes (AGOs) which is the 
central effectors [14, 15]. The TNRC6 members have the 
functional redundancy [16], and thus, been speculated 
about playing a role in a tissue-or cell-specific manner 
[17]. We suppose that Zfp819 regulates gene expression 
of members in TNRC6 family, each different members in 
different cell lines.
Of 118 down-regulated genes by microarray, we found 
10 genes showing an anti-apoptotic function in the 
Fig. 6 Direct regulation of Tnrc6b and Anxa11 by ZFP819. a Schematic diagrams of Tnrc6b and Anxa11 promoters. Black boxes mean sites including 
probes used for ChIP-chip experiment. b Western blotting of GC-2 cells at 24 h after transfection with Zfp819 or empty vector. The α-tubulin protein 
was used as a control. Analysis of Tnrc6b (c) and Anxa11 (d) promoters. GC-2 cells were cotransfected with each promoter-luciferase constructs and 
Zfp819 or empty vector. Promoter activity was evaluated in dual-luciferase assays. pGL3-promoter vector was used as a control. Experiments were 
conducted in triplicate. The data are expressed as the mean ± SEM; *p < 0.05, **p < 0.01 versus mock (Student’s t test)
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previous studies (Table 1). Two (Ctsh, and Mtdh) of them 
regulate expression of proteins belonging to Bcl-2 fam-
ily [18, 19]. Cbx7 as a component of polycom repressive 
complex 1 has functions in cancer cell development and 
extension of cellular life span [20]. A recent paper dem-
onstrated that apoptotic cells increased via expression of 
tumor necrosis factor-related-apoptosis-inducing ligand 
(TRAIL) in Cbx7-silenced condition [20]. Fbxw11 and 
Fig. 7 Expression analysis of Tnrc6b and Anxa11. a The transcript levels of Tnrc6b and Anxa11 were examined by qRT-PCR in mock vector- or Zfp819-
transfected cells. The qRT-PCR data of Tnrc6b and Anxa11 were normalized with that of Gapdh. Experiments were repeated three times. The data are 
expressed as the mean ± SEM; *p < 0.05 and **p < 0.001 (Student’s t test). b, c The expression of TNRC6B in Zfp819-overexpressing cells. Expression 
level of TNRC6B were examined at 48 h post-transfection by Western blotting (b), and the intensities of the bands were quantified (c). The data are 
expressed as the mean ± SEM (n = 3); *p < 0.01. d Tissue distributions of Tnrc6b and Anxa11. Complementary DNAs from eight different mouse 
adult tissues and two different cell lines were subjected to RT-PCR analysis. The glyceraldehyde-3-phosphate dehydrogenase (Gapdh) gene was 
used as a control. e Western blotting demonstrated the expression of TNRC6B in eight different mouse adult tissues. GAPDH was used as a control
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Itsn1 are involved in apoptosis by modulating expres-
sion of downstream genes in mitogen-activated protein 
kinases (MAPK) family [21, 22]. On the other hand, seven 
genes selected by microarray in NIH 3T3 cells play a role 
in apoptosis by affecting the expression of downstream 
effectors of p53 or depending on p53 [5, 23–25]. Thus, 
the selected genes in both cell lines control the expres-
sion of multiple steps in apoptosis, ultimately activating 
Caspase-3 or PARP, although they individually regulate 
several proteins in different pathways.
Furthermore, we defined the genomic target sites of 
Zfp819 by ChIP-chip technique in GC-2 cells. Of the 
enriched 1011 promoter sites (262 genes) by Zfp819, 
surprisingly, only two genes (Tnrc6b and Anxa11) were 
selected by two different genome-wide approaches 
(microarray and ChIP-chip). This suggests that most of 
the down-regulated genes in the microarray analysis are 
indirectly regulated by Zfp819. Alternatively, it is possi-
ble that transfection efficiency of Zfp819 influences on 
expression of downstream genes, in spite of the same 
condition in two different experiments. In addition, 
ChIP-chip technique sometimes generates a high ratio of 
signal-to-noise, thereby selecting a large number of peaks 
[26]. These results were also obtained in other similar 
studies [27–29].
So far, apoptosis has been considered an important 
process at every stages during spermatogenesis [30]. As 
undergoing mitosis, meiosis, and post-meiosis sequen-
tially, cells need to keep a balance between prolifera-
tion and apoptosis for producing normal sperm. There 
is high possibility of occurring many of errors for mito-
sis and meiosis, and cell death by apoptosis is necessary 
to remove those cells with generic defects. In terminal 
differentiation, apoptosis generally occurs to remove 
cytoplasmic components, producing highly specialized 
cells.
Both Tnrc6b and Anxa11 are heavily involved in apop-
tosis. As mentioned the above, TNRC6B is an interact-
ing partner of Ago2 and forms a complex with miRNA 
induced-silencing complex (miRISC) [15, 31]. This com-
plex participates in two different ways for silencing of 
mRNA: mRNA decay and translational repression [32]. 
In these processes, miRNAs have an important role by 
recognizing their mRNA targets. MiRNAs are essen-
tial to control the temporal and spatial gene expression 
at every stages during spermatogenesis as well [33]. For 
example, miR-34c, expressed from pachytene spermato-
cyte, promotes the apoptosis of germ cells via balancing 
expressions between the Bcl-2 and BCL2 associated X 
protein (Bax) genes [34]. Additionally, miR-34c activates 
the expression of transcription factor 1 (Atf1), and then 
decreases Bax expression in knockdown of Atf1, conse-
quently, inducing germ cell apoptosis [34].
Anxa11 encodes a calcium-dependent phospholipid-
binding protein. During cell cycle, ANXA11 shows 
a dynamic pattern from nucleus to nuclear envelop 
with co-localization of S100A6, a small calcium bind-
ing protein [35, 36]. In Anxa11-silenced condition, the 
siRNA-transfected cells appeared the incompletion of 
cytokinesis generating many of binucleate cells, thereby 
leading to apoptosis by increasing the expression of PARP 
[36]. So far, the mechanism that Anxa11 is involved 
in apoptosis exactly has not been discovered. A recent 
study indicated that the knockdown of Anxa11 decreased 
proliferation and survival of hepatocarcinoma cells by 
increasing expression of thymoma viral proto-oncogene 
2 (AKT2) and phospholylated forkhead box O1 (FOXO1) 
[37]. Thus, this suggests that Anxa11 is involved in cell 
survival or apoptosis in different cell types.
Conclusion
In summary, we herein investigate cellular effects and tar-
get genes influenced by Zfp819 in GC-2 cells. The over-
expression of Zfp819 induced apoptosis and inhibited 
cellular proliferation. We identified two genes regulated 
by Zfp819 by microarray and ChIP-chip analysis. Interest-
ingly, both of two genes showed the predominant expres-
sion in testis. Previously, these genes were found to play 
an important role in apoptosis. Taken together, our study 
provides new information about germ cell-specific gene 
regulation by Zfp819 which potentially functions in main-
taining the integrity of spermatogenesis through apoptosis.
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